Details of the Drug

General Information of Drug (ID: DMZNGJL)

Drug Name

Cintredekin besudotox

Indication

Disease Entry	ICD 11	Status	REF
Brain cancer	2A00	Phase 3	[1]
------------------------------------------------------------------------------------

Cross-matching ID

References

1	ClinicalTrials.gov (NCT00076986) The PRECISE Trial: Study of IL13-PE38QQR Compared to GLIADEL Wafer in Patients With Recurrent Glioblastoma Multiforme. U.S. National Institutes of Health.